Alaunos Therapeutics (TCRT) Stock Chart & Stock Price History $2.63 +0.09 (+3.58%) As of 11:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alaunos Therapeutics Stock Price Performance The Alaunos Therapeutics (TCRT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.70%, with a year-to-date return of 38.47%. In the past month, the stock has increased 9.62%, reflecting recent market activity. As of the latest close, Alaunos Therapeutics traded at $2.54 with a market cap of $4.17 million and volume of 6,988 shares. Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.36%1 Month Performance+9.62%3 Month Performance+56.61%Year-To-Date Performance+38.47%1 Year Performance-74.70% TCRT Stock Chart for Thursday, May, 22, 2025 TCRT Chart by TradingView Alaunos Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$2.64$2.54-3.79%$2.62$2.506,988 shs$4.17 million05/20/2025$2.69$2.64-1.86%$2.67$2.4910,159 shs$4.33 million05/19/2025$2.84$2.69-5.28%$2.93$2.6228,801 shs$4.41 million05/16/2025$2.82$2.84+0.71%$2.95$2.804,268 shs$4.66 million05/15/2025$2.89$2.82-2.42%$2.91$2.775,236 shs$4.63 million05/14/2025$2.88$2.89+0.35%$2.95$2.8316,417 shs$4.74 million05/13/2025$2.85$2.88+1.05%$2.94$2.8111,161 shs$4.72 million05/12/2025$2.85$2.85$2.93$2.827,287 shs$4.67 million05/09/2025$3.01$2.85-5.32%$3.06$2.8115,729 shs$4.67 million05/08/2025$2.87$3.01+4.88%$3.01$2.7925,498 shs$4.94 million Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$2.90$2.87-1.03%$2.90$2.5627,751 shs$4.71 million05/06/2025$2.85$2.90+1.75%$2.91$2.7120,832 shs$4.76 million05/05/2025$2.53$2.85+12.65%$2.85$2.4546,737 shs$4.56 million05/02/2025$2.24$2.53+12.95%$2.57$2.2264,142 shs$4.05 million05/01/2025$2.45$2.24-8.57%$2.45$2.0225,824 shs$3.59 million04/30/2025$2.38$2.45+2.94%$2.49$2.3312,928 shs$3.92 million04/29/2025$2.45$2.38-2.86%$2.47$2.3310,576 shs$3.81 million04/28/2025$2.63$2.45-6.84%$2.86$2.3263,411 shs$3.92 million04/25/2025$2.68$2.63-1.87%$2.86$2.5617,815 shs$4.21 million04/24/2025$2.46$2.68+8.94%$2.77$2.4723,328 shs$4.29 million04/23/2025$2.40$2.46+2.50%$2.54$2.4112,603 shs$3.94 million04/22/2025$2.35$2.40+2.13%$2.48$2.2751,700 shs$3.84 million04/21/2025$2.48$2.35-5.24%$2.47$2.3013,065 shs$3.76 million Related Companies Leap Therapeutics Stock Price Chart Gelteq Stock Price Chart AlloVir Stock Price Chart Allarity Therapeutics Stock Price Chart Cingulate Stock Price Chart GeoVax Labs Stock Price Chart X4 Pharmaceuticals Stock Price Chart Cocrystal Pharma Stock Price Chart Flora Growth Stock Price Chart Trinity Biotech Stock Price Chart Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
